Sökresultat - "Metabolic dysfunction"

Higher Residual and Metabolic Dysfunction-Associated Fatty Liver Disease Risk of the R-Enantiomer of Famoxadone in Mice

Hu, Zeyu, Xiao, Shouchun, Yao, Jianing, Cao, Yue, He, Bingying, Yang, Jiaxing, Zhao, Fanrong, Zheng, Li, Liu, Donghui, Zhou, Zhiqiang, Liu, Xueke, Wang, Peng

Impact of High-Fat Diet-induced Metabolic Dysfunction-associated Steatotic Liver Disease on Heart, Kidney, and Skeletal Muscle Metabolomes in Wild-Type Mice

Silva, João G.^{aff1, aff2, aff3, aff5}, Tavares, Ludgero^{aff1, aff3}, Belew, Getachew D.^{aff1, aff4}, Rodrigues, João A.^aff5, Araújo, Rita^aff5, Gil, Ana M.^aff5, Jones, John G.^aff1

Ta4C3 MXene Slows Progression of Fatty Liver Disease through Its Anti-Inflammatory and ROS-Scavenging Effects

He, Shuying^aff1, Lv, Yuerong^aff1, Qiu, Jingnan^aff1, Cui, Shudan^aff1, Gao, Zixian^aff1, Peng, Liang^{aff1, aff2}

Metabolic Dysfunction-Associated Steatotic Liver Disease and Pancreatic Disease: A Population-Based Nationwide Cohort and Sibling-Controlled Study

Vujasinovic, Miroslav, Ebrahimi, Fahim, Roelstraete, Bjorn, Bergman, David, Sun, Jiangwei, Sadr-Azodi, Omid, Löhr, J. -Matthias, Ludvigsson, Jonas F.

electronic

Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future

Fernando, Kevin^{Aff1, IDs13300025017383_cor1}, Connolly, Derek^{Aff2, Aff3}, Darcy, Eimear, Evans, Marc, Hinchliffe, William, Holmes, Patrick, Strain, W. David

Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data

Wang, Hao^{Aff1, Aff2}, Xu, Xiaoqian^{Aff1, Aff2}, Shi, Lichen^{Aff1, Aff2}, Huang, Cheng^{Aff1, Aff2}, Sun, Yameng^{Aff1, Aff2}, You, Hong^{Aff1, Aff2}, Jia, Jidong^{Aff1, Aff2}, He, You-Wen, Kong, Yuanyuan^{Aff1, Aff2, IDs12072024107752_cor1}

Aging and metabolic dysfunction-associated steatotic liver disease: a bidirectional relationship

Chen, Chen, Wang, Lin^{Aff1, IDs1168402511337_cor1}

New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024

Wong, Shu Wei^Aff1, Yang, Yong-yu^Aff1, Chen, Hui, Xie, Li, Shen, Xi-zhong^{Aff2, Aff3}, Zhang, Ning-ping^{Aff2, Aff3, IDs41401024014667_cor1}, Wu, Jian^{Aff1, Aff2, Aff3, IDs41401024014667_cor2}

Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD

Hanamatsu, Hisatoshi^Aff1, Suda, Goki^Aff2, Ohara, Masatsugu, Ogawa, Koji, Tamaki, Nobuharu, Hikita, Hayato, Haga, Hiroaki, Maekawa, Shinya, Sugiyama, Masaya, Kakisaka, Tatsuhiko, Nakai, Masato, Sho, Takuya, Miura, Nobuaki, Kurosaki, Masayuki, Asahina, Yasuhiro, Taketomi, Akinobu, Ueno, Yoshiyuki, Takehara, Tetsuo, Nishikaze, Takashi, Furukawa, Jun-ichi^{Aff1, Aff11, IDs00535024022068_cor1}, Sakamoto, Naoya^{Aff2, IDs00535024022068_cor2}

Prevent and Reverse Metabolic Dysfunction-Associated Steatohepatitis and Hepatic Fibrosis via mRNA-Mediated Liver-Specific Antibody Therapy

Zhang, Chenshuang^aff1, Teng, Yilong^aff1, Bai, Xin^aff1, Tang, Maoping^aff1, Stewart, William^{aff2, aff3}, Chen, Jake Jinkun^{aff4, aff5}, Xu, Xiaoyang^{aff2, aff3}, Zhang, Xue-Qing^aff1

Multiomics Studies on Metabolism Changes in Alcohol-Associated Liver Disease

He, Liqing^{aff1, aff2, aff3, aff4}, Xu, Raobo^{aff1, aff2, aff3, aff4}, Ma, Xipeng^{aff1, aff2, aff3, aff4}, Yin, Xinmin^{aff1, aff2, aff3, aff4}, Mueller, Eugene^aff1, Feng, Wenke^{aff2, aff3, aff4, aff5, aff6}, Menze, Michael^aff7, Kim, Seongho^{aff8, aff9}, McClain, Craig J.^{aff2, aff3, aff5, aff6, aff10}, Zhang, Xiang^{aff1, aff2, aff3, aff4, aff5}

Transgenerational Effects of the Obesogen Tributyltin on Metabolic Health in Mice: Interactions With a Western Diet

Chang, Richard C, Huang, Yikai, To, Kaitlin, Whitlock, Ryan Scott, Nguyen, Katelyn Uyen, Joemon, Michelle Clara, Lopez, Miranda, Deeprompt, Kritin Guy, Shioda, Toshi, Blumberg, Bruce

Overview of the hazardous impacts of metabolism-disrupting chemicals on the progression of fatty liver diseases.

An, Garam, Song, Jisoo, Ying, Wei, Lim, Whasun

application/pdf

Sarcopenic Obesity and MASLD: A Dangerous Duo Driving Deadly Cardiometabolic Risk

Channapragada, Theja, Stine, Jonathan G.^{Aff2, Aff3, Aff4, Aff5, Aff6, IDs10620025091077_cor1}

Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study

Lee, Jong Hee^{Aff1, Aff2}, Ryu, Ha-Eun^{Aff1, Aff2}, Han, Taehwa, Park, Byoungjin^{Aff1, Aff2}, Heo, Seok-Jae^{Aff4, IDs12020025042003_cor1}, Kwon, Yu-Jin^{Aff1, Aff2, IDs12020025042003_cor2}

The correlation between metabolic dysfunction-associated steatotic liver disease (MASLD) grades and hemodynamic alterations of the portal, hepatic, and splenic vein and spleen size

Borji, Soheila, Sani, Hadi Sabat, Ghorbani, Saharnaz, Soltani, Mohammad, Mohammadi, Vahid, Elahi, Reza^{Aff1, Aff2, IDs4047702400965x_cor1}

Dietary Intake of Major Minerals and Trace Elements in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Implications for Dietary Intervention

Isakov, Vasily, Sasunova, Armida, Morozov, Sergey^{Aff1, Aff2, IDs1232502503238z_cor1}, Goncharov, Alexei

Tilorone attenuates high-fat diet-induced hepatic steatosis by enhancing BMP9-Smad1/5/8 signaling

Horvath, Barnabas, Halasz, Judit, Tanner, Norman Noel, Kohler, Zoltan Marton, Trencsenyi, Gyorgy, Juhasz, Laszlo, Rovo, Laszlo, Kiss, Andras, Keller-Pinter, Aniko^{Aff1, Aff6, IDs11357025016858_cor1}

Body mass index-specific metabolic profiles in schizophrenia: implications for cognitive dysfunction and psychopathology

Zeng, Min^Aff1, Wang, Xinxu^{Aff2, Aff3}, Zhou, Jianan^Aff1, Zhang, Xiao, Zhang, Xiaofei, Chi, Jinghui, Lu, Chenghao, Wang, Lili^{Aff1, Aff2, IDs0070202502951x_cor1}, Li, Shen^{Aff2, Aff3, IDs0070202502951x_cor2}

Metabolic Dysfunction-Associated Steatotic Liver Disease and Chronic Kidney Disease: Unraveling Connections and Advancing Therapies

Lian, Kexin^{Aff1, Aff2}, Fan, Qiming^{Aff1, Aff2}, Sheng, Sufang^{Aff2, Aff3}, Zhang, Kexin^{Aff2, Aff3}, Sun, Xiaodong^{Aff2, Aff3}, Kan, Chengxia^{Aff2, Aff3}, Pan, Ruiyan^{Aff4, Aff5, IDs44411025001893_cor1}, Guo, Zhentao^{Aff1, Aff2, IDs44411025001893_cor2}